Squar Milner Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

Squar Milner Financial Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,900	Closed	-$18K	–	859
2019 Q4	$18K	Buy	+1,900	New	+$17K	0.01%	537
2019 Q3	–	Sell	-1,900	Closed	-$18K	–	663
2019 Q2	$18K	Hold	1,900	–	–	0.01%	467
2019 Q1	$29K	Hold	1,900	–	–	0.02%	386
2018 Q4	$29K	Hold	1,900	–	–	0.03%	356
2018 Q3	$41K	Sell	1,900 -245	-11%	-$5.69K	0.04%	324
2018 Q2	$52K	Buy	+2,145	New	+$43.7K	0.05%	323

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Squar Milner Financial Services's TEVA Position: Q1 2020 in Review

Squar Milner Financial Services sold out of Teva Pharmaceuticals (TEVA) in Q1 2020, closing a stake of 1,900 shares — an estimated $18K sold.

Squar Milner Financial Services first reported a position in TEVA in Q2 2018 and held it in 6 quarters. The position peaked at $52K in Q2 2018. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

Squar Milner Financial Services reported no remaining Teva Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Squar Milner Financial Services sold 1,900 Teva Pharmaceuticals shares in Q1 2020, an estimated $18K.
Squar Milner Financial Services first reported a position in Teva Pharmaceuticals in Q2 2018 and held it in 6 quarters.
Squar Milner Financial Services's Teva Pharmaceuticals position peaked at $52K in Q2 2018.
459 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2020.

Based on Squar Milner Financial Services's 13F filing for Q1 2020, filed 22 Apr 2020.